Sía eftir: Last updated date SelectEftirFyrirFrom - To Date Lokadagsetning This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorPRIMEParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Niðurstöður (3828) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Regulatory information – adjusted fees for applications to EMA from 1 April 2023 31 mars 2023NewsCorporate Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 27 - 30 March 2023 31 mars 2023NewsHumanCOVID-19MedicinesVaccines EMA recommends approval of Bimervax as a COVID-19 booster vaccine 30 mars 2023NewsHumanCOVID-19MedicinesVaccines DARWIN EU® has completed its first studies and is calling for new data partners 28 mars 2023NewsHumanData on medicinesMedicines Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 21-22 March 2023 24 mars 2023NewsVeterinaryMedicines Advancing regulatory science in the EU – mid-point report published 22 mars 2023NewsHumanVeterinaryCorporateInnovationResearch and development EMA Management Board: highlights of March 2023 meeting 17 mars 2023NewsCorporate Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 13 - 16 March 2023 17 mars 2023NewsHumanPharmacovigilanceReferrals Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 6-8 December 2022 15 mars 2023NewsVeterinaryMedicines Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 14-16 February 2023 10 mars 2023NewsVeterinaryMedicines 1 … 32 33 34 35 36 Page 36 of 383 37 38 39 40 … 383
Regulatory information – adjusted fees for applications to EMA from 1 April 2023 31 mars 2023NewsCorporate
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 27 - 30 March 2023 31 mars 2023NewsHumanCOVID-19MedicinesVaccines
EMA recommends approval of Bimervax as a COVID-19 booster vaccine 30 mars 2023NewsHumanCOVID-19MedicinesVaccines
DARWIN EU® has completed its first studies and is calling for new data partners 28 mars 2023NewsHumanData on medicinesMedicines
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 21-22 March 2023 24 mars 2023NewsVeterinaryMedicines
Advancing regulatory science in the EU – mid-point report published 22 mars 2023NewsHumanVeterinaryCorporateInnovationResearch and development
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 13 - 16 March 2023 17 mars 2023NewsHumanPharmacovigilanceReferrals
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 6-8 December 2022 15 mars 2023NewsVeterinaryMedicines
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 14-16 February 2023 10 mars 2023NewsVeterinaryMedicines